Search in:

Advanced search

International Journal of Chronic Obstructive Pulmonary Disease Volume 8, 2013 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Indacaterol improves daily physical activity in patients with chronic obstructive pulmonary disease

Osamu Hataji1 Respiratory Center, Matsusaka Municipal Hospital, Tonomachi

Masahiro Naito1 Respiratory Center, Matsusaka Municipal Hospital, Tonomachi

Kentaro Ito1 Respiratory Center, Matsusaka Municipal Hospital, Tonomachi

Fumiaki Watanabe1 Respiratory Center, Matsusaka Municipal Hospital, Tonomachi

Esteban C Gabazza2 Department of Immunology, Mie University Graduate School of Medicine, Mie, JapanCorrespondence[email protected]

Osamu Taguchi3 Department of Pulmonary and Critical Care Medicine, Mie University Graduate School of Medicine, Mie, Japan

Pages 1-5 | Published online: 28 Dec 2012

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

RabeKFHurdSAnzuetoAGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med200717653255517507545
PubMed Web of Science ®Google Scholar
RycroftCEHeyesALanzaLBeckerKEpidemiology of chronic obstructive pulmonary disease: a literature reviewInt J Chron Obstruct Pulmon Dis2012745749422927753
PubMed Web of Science ®Google Scholar
BarnesPJImmunology of asthma and chronic obstructive pulmonary diseaseNat Rev Immunol2008818319218274560
PubMed Web of Science ®Google Scholar
TashkinDPFabbriLMLong-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agentsRespir Res20101114921034447
PubMed Web of Science ®Google Scholar
BeierJBeehKMLong-acting beta-adrenoceptor agonists in the management of COPD: focus on indacaterolInt J Chron Obstruct Pulmon Dis2011623724321814459
PubMed Web of Science ®Google Scholar
McKeageKIndacaterol: a review of its use as maintenance therapy in patients with chronic obstructive pulmonary diseaseDrugs20127254356322356291
PubMed Web of Science ®Google Scholar
CopeSZhangJWilliamsJJansenJPEfficacy of once-daily indacaterol 75 mug relative to alternative bronchodilators in COPD: a study level and a patient level network meta-analysisBMC Pulm Med2012122922732017
PubMed Web of Science ®Google Scholar
RibeiroMChapmanKRComparative efficacy of indacaterol in chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2012714515222419862
PubMed Web of Science ®Google Scholar
RossiACentanniSCerveriIAcute effects of indacaterol on lung hyperinflation in moderate COPD: a comparison with tiotropiumRespir Med2011106849022035851
PubMed Web of Science ®Google Scholar
MrozRMMinarowskiLChyczewskaEIndacaterol add-on therapy improves lung function, exercise capacity and life quality of COPD patientsAdv Exp Med Biol2013756232822836615
PubMed Web of Science ®Google Scholar
O’DonnellDECasaburiRVinckenWEffect of indacaterol on exercise endurance and lung hyperinflation in COPDRespir Med20111051030103621498063
PubMed Web of Science ®Google Scholar
CasaburiRActivity monitoring in assessing activities of daily livingCOPD2007425125517729069
PubMedGoogle Scholar
CazzolaMSegretiAStirpeEAppodiaMSenisLMateraMGEnergy expenditure and impact of bronchodilators in COPD patientsRespir Med20101041490149420471237
PubMed Web of Science ®Google Scholar
LahaijeAJvan HelvoortHADekhuijzenPNHeijdraYFPhysiologic limitations during daily life activities in COPD patientsRespir Med20101041152115920346641
PubMed Web of Science ®Google Scholar
PittaFTroostersTSpruitMAProbstVSDecramerMGosselinkRCharacteristics of physical activities in daily life in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200517197297715665324
PubMed Web of Science ®Google Scholar
WaschkiBSpruitMAWatzHPhysical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter studyRespir Med201210652253022118987
PubMed Web of Science ®Google Scholar
WatzHWaschkiBMeyerTMagnussenHPhysical activity in patients with COPDEur Respir J20093326227219010994
PubMed Web of Science ®Google Scholar
BenzoRPChangCCFarrellMHPhysical activity, health status and risk of hospitalization in patients with severe chronic obstructive pulmonary diseaseRespiration201080101820234126
PubMed Web of Science ®Google Scholar
Garcia-RioFRojoBCasitasRPrognostic value of the objective measurement of daily physical activity in COPD patientsChest201214233834622281798
PubMed Web of Science ®Google Scholar
PittaFTroostersTProbstVSSpruitMADecramerMGosselinkRPhysical activity and hospitalization for exacerbation of COPDChest200612953654416537849
PubMed Web of Science ®Google Scholar
WaschkiBKirstenAHolzOPhysical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort studyChest201114033134221273294
PubMed Web of Science ®Google Scholar
WaschkiBSpruitMAWatzHPhysical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter studyRespir Med201210652253022118987
PubMed Web of Science ®Google Scholar
ATS Committee on Proficiency Standards for Clinical Pulmonary Function LaboratoriesATS statement: guidelines for the six-minute walk testAm J Respir Crit Care Med200216611111712091180
PubMed Web of Science ®Google Scholar
MackayAJDonaldsonGCPatelARJonesPWHurstJRWedzichaJAUsefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbationsAm J Respir Crit Care Med20121851218122422281834
PubMed Web of Science ®Google Scholar
KumaharaHSchutzYAyabeMThe use of uniaxial accelerometry for the assessment of physical-activity-related energy expenditure: a validation study against whole-body indirect calorimetryBr J Nutr20049123524314756909
PubMed Web of Science ®Google Scholar
DahlRChungKFBuhlREfficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPDThorax20106547347920522841
PubMed Web of Science ®Google Scholar
FeldmanGSilerTPrasadNEfficacy and safety of indacaterol 150 microg once-daily in COPD: a double-blind, randomised, 12-week studyBMC Pulm Med2010101120211002
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Indacaterol improves daily physical activity in patients with chronic obstructive pulmonary disease

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Indacaterol improves daily physical activity in patients with chronic obstructive pulmonary disease

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date